Clinical Trial

Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study goals are to determine the patterns of uterine fibroid vascularity pre and post UAE using CEUS resulting in an alternative to gadolinium-enhanced MRI that is less expensive, has less contra-indications and side effects, is real time, and noninvasive helping physicians to evaluate the result of UAE procedures. Also, this study will evaluate uterine fibroid pressures using SHAPE, comparing the results with normal myometrium tissue in order to determine its characteristics and tissue differences, which we believe will lead to the development of a new biomarker for the diagnosis and treatment of uterine fibroids.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-21.
Status change: Not Yet Recruiting → Recruiting 2025-04-07
Trial Details
NCT Number NCT06705075
Lead Sponsor Thomas Jefferson University
Conditions Uterine Fibroid
Enrollment 80 participants
Start Date 2025-01-27
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-10